Physician profile
Subhash Gutti
NPI 1760132963
$5,018.04
in general payments reported to CMS, 2019-2025
11 companies · $3,851 in 2025
The $3,851 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $72.83 · 2024: $1,094 · 2025: $3,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,144 · Travel and Lodging: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,144.47 |
| Travel and Lodging | $873.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,251.72 | 2025 | Clottriever Bold Catheter, Artix Mt, Flowtriever Catheter, S |
| Inari Medical, INC. | $752.90 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Medical LLC | $693.90 | 2024-2025 | Zilver Ptx, Rosch-Uchida, Tornado |
| Boston Scientific Corporation | $448.24 | 2023-2025 | Embold Fibered, Ranger, Obsidio |
| Penumbra, INC. | $336.82 | 2024-2025 | Indigo System, Ruby Coil |
| W. L. Gore & Associates, INC. | $316.10 | 2023-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
| Trisalus Life Sciences, INC. | $104.38 | 2024-2025 | Trinav Infusion System |
| Thrombolex, INC. | $41.24 | 2025 | Bashir Endovascular Catheter |
| Okami Medical, INC. | $33.78 | 2025 | Lobo |
| Angiodynamics, INC. | $22.23 | 2025 | Alphavac |
| Shockwave Medical, INC | $16.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhash Gutti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.